PAPAIJV
LH icon

Paragon Associates & Paragon Associates II Joint Venture’s Labcorp LH Stock Holding History

Paragon Associates & Paragon Associates II Joint Venture’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-582
Closed -$121K – 13
2023
Q2 		$121K Hold
582
– – 0.25% 13
2023
Q1 		$115K Hold
582
– – 0.24% 11
2022
Q4 		$118K Sell
582
-2,328
-80% -$455K 0.22% 17
2022
Q3 		$512K Buy
+2,910
New +$596K 1.03% 12

Other funds holding LH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Paragon Associates & Paragon Associates II Joint Venture's LH Position: Q3 2023 in Review

Paragon Associates & Paragon Associates II Joint Venture sold out of Labcorp (LH) in Q3 2023, closing a stake of 582 shares — an estimated $121K sold.

Paragon Associates & Paragon Associates II Joint Venture first reported a position in LH in Q3 2022 and held it in 4 quarters. The position peaked at $512K in Q3 2022. 882 funds tracked by Wall St. Rank hold LH as of Q3 2023.

  • Paragon Associates & Paragon Associates II Joint Venture reported no remaining Labcorp position as of Q3 2023 after selling out during the quarter.
  • Paragon Associates & Paragon Associates II Joint Venture sold 582 Labcorp shares in Q3 2023, an estimated $121K.
  • Paragon Associates & Paragon Associates II Joint Venture first reported a position in Labcorp in Q3 2022 and held it in 4 quarters.
  • Paragon Associates & Paragon Associates II Joint Venture's Labcorp position peaked at $512K in Q3 2022.
  • 882 funds tracked by Wall St. Rank held Labcorp as of Q3 2023.

Based on Paragon Associates & Paragon Associates II Joint Venture's 13F filing for Q3 2023, filed 14 Nov 2023.